The Comparative Results of Progestin Primed Ovarian Stimulation (PPOS) and GnRH Antagonist Ovarian Stimulation Methods on IVF Outcomes

This clinical trial aims to compare two different methods of ovarian stimulation used in in vitro fertilization (IVF): Progestin Primed Ovarian Stimulation (PPOS) and GnRH Antagonist. The study focuses on women undergoing IVF treatment to see which method results in better embryologic outcomes. Understanding which approach is more effective could help improve the success rates of IVF treatments, providing better options for those trying to conceive. Participants in the study will be assigned to one of the two stimulation methods. For those in the artificially prepared cycle group, the medication Estradiol Hemihydrate will be taken orally starting on the second day of the menstrual cycle. After two weeks, doctors will measure the thickness of the uterine lining and progesterone levels to ensure the cycle can continue. For luteal support, Progesterone is administered both by injection and vaginally at specific times during the cycle. Embryo transfer takes place on the sixth day after starting progesterone treatment, with continued hormone support to aid pregnancy development up to eight weeks. This study does not specify risks or benefits, focusing on comparing the effectiveness of the two stimulation methods.